Published in Stem Cells on January 01, 2013
Role of ErbB Receptors in Cancer Cell Migration and Invasion. Front Pharmacol (2015) 1.02
Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm. J Invest Dermatol (2013) 1.01
Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis (2013) 0.96
Cell-derived matrices for tissue engineering and regenerative medicine applications. Biomater Sci (2015) 0.92
Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion. Lab Invest (2013) 0.90
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med (2013) 0.88
The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A (2013) 0.86
Stem cell death and survival in heart regeneration and repair. Apoptosis (2016) 0.84
Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass. Sci Rep (2014) 0.78
Improved transplanted stem cell survival in a polymer gel supplemented with tenascin-C accelerates healing and reduces scarring of murine skin wounds. Cell Transplant (2016) 0.77
Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury. Adv Pharm Bull (2015) 0.77
Epidermal Growth Factor Tethered to β-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice. Stem Cells Transl Med (2016) 0.75
Interferon‑γ alters the microRNA profile of umbilical cord‑derived mesenchymal stem cells. Mol Med Rep (2016) 0.75
Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLCγ1. FASEB J (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25
Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67
EGF receptor. Int J Biochem Cell Biol (1999) 3.91
Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science (2005) 3.37
Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med (2011) 3.11
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (1990) 2.92
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med (2012) 2.80
Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A (2004) 2.46
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells (2005) 2.37
Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells (2007) 2.03
Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun (2002) 1.89
Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation (2009) 1.73
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells (2005) 1.66
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One (2008) 1.60
Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials (2011) 1.58
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57
Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem (2004) 1.55
Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol (2010) 1.46
Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther (2010) 1.39
Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med (1996) 1.36
Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell (1996) 1.35
Mesenchymal stem cells and bone regeneration: current status. Injury (2011) 1.34
Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ (2009) 1.26
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells (2011) 1.19
Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem (2010) 1.17
Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol (2010) 1.16
Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells (2009) 1.11
Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am (2008) 1.10
Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol (2007) 1.10
m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J Biol Chem (2010) 1.07
In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res (2009) 1.05
Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol (1996) 1.04
Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem (2009) 1.03
Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol (2007) 1.02
Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Eng Part A (2011) 1.02
Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol (2009) 1.02
Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci (2011) 1.00
Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress. J Cell Biochem (2010) 0.95
Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res (2009) 0.93
Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules (2009) 0.92
The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials (2009) 0.90
In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med (2011) 0.89
Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transplant (2012) 0.87
Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways. Cytotherapy (2010) 0.87
Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling. Biomaterials (2011) 0.87
In vivo molecular imaging of murine embryonic stem cells delivered to a burn wound surface via Integra® scaffolding. J Burn Care Res (2012) 0.82
White adipocytes are less prone to apoptotic stimuli than brown adipocytes in rodent. Cell Death Differ (2006) 0.82
Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A (2006) 7.48
Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol (2002) 2.38
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer (2010) 2.31
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev (2012) 2.08
Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells (2007) 2.03
Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair. J Invest Dermatol (2003) 1.89
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells (2005) 1.66
Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol (2002) 1.64
IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res (2006) 1.61
Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene (2005) 1.56
Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem (2004) 1.55
Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. J Biol Chem (2004) 1.41
EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation. J Cell Sci (2007) 1.40
Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen (2004) 1.39
Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther (2010) 1.39
IP-10 induces dissociation of newly formed blood vessels. J Cell Sci (2009) 1.38
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol (2007) 1.38
Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron (2011) 1.37
Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol (2005) 1.35
Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol (2008) 1.34
Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol (2006) 1.31
Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J Cell Physiol (2009) 1.30
ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol (2008) 1.29
Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci U S A (2010) 1.28
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp Cell Res (2004) 1.28
Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell (2008) 1.27
Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation. Wound Repair Regen (2002) 1.27
Modeling of signal-response cascades using decision tree analysis. Bioinformatics (2005) 1.27
2D protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagen. J Cell Biol (2012) 1.26
Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res (2007) 1.25
Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. Clin Chem (2006) 1.22
Absence of inhibition of cutaneous wound healing in mice by oral doxycycline. Wound Repair Regen (2003) 1.18
Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol (2010) 1.16
Distribution of gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. Int J Biochem Cell Biol (2002) 1.16
Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res (2003) 1.15
Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev (2008) 1.15
Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res (2003) 1.14
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene (2005) 1.13
CSR1 suppresses tumor growth and metastasis of prostate cancer. Am J Pathol (2006) 1.13
Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells (2009) 1.11
Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. J Biol Chem (2011) 1.11
α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One (2010) 1.11
Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am (2008) 1.10
Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3. Wound Repair Regen (2009) 1.10
Expression of myopodin induces suppression of tumor growth and metastasis. Am J Pathol (2004) 1.10
Directional motility induced by epidermal growth factor requires Cdc42. Exp Cell Res (2003) 1.08
The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials (2007) 1.08
Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. Am J Pathol (2010) 1.07
m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J Biol Chem (2010) 1.07
Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. Am J Pathol (2010) 1.06
Calpains as potential anti-cancer targets. Expert Opin Ther Targets (2011) 1.05
Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun (2006) 1.04
The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res (2013) 1.04
Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci U S A (2012) 1.04
Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem (2009) 1.03
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol Cancer (2012) 1.03
Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility. BMC Syst Biol (2007) 1.03
Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol (2007) 1.02
Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol (2009) 1.02
Both actin and polyproline interactions of profilin-1 are required for migration, invasion and capillary morphogenesis of vascular endothelial cells. Exp Cell Res (2009) 1.01
Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res (2006) 1.01
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis (2011) 1.01
Multiple signaling pathways mediate compaction of collagen matrices by EGF-stimulated fibroblasts. Exp Cell Res (2006) 1.00
EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int J Cancer (2002) 1.00
Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen (2006) 0.99
Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. J Cell Physiol (2009) 0.98
Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol (2010) 0.97
Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients. Anticancer Res (2008) 0.96
Engineering liver. Hepatology (2014) 0.95
Modulation of osteoblast gap junction connectivity by serum, TNFalpha, and TRAIL. Exp Cell Res (2007) 0.94
The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells. J Biol Chem (2014) 0.94
Matrix control of scarring. Cell Mol Life Sci (2011) 0.93
Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts. Mol Cell Proteomics (2011) 0.92
Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors. In Vitro Cell Dev Biol Anim (2003) 0.92
Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar. Otolaryngol Head Neck Surg (2006) 0.92
Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. Clin Cancer Res (2008) 0.92
Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol (2012) 0.91
Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility. J Cell Sci (2007) 0.91
The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials (2009) 0.90
Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. J Proteome Res (2010) 0.90
Intercellular transfer of proteins as identified by stable isotope labeling of amino acids in cell culture. J Biol Chem (2009) 0.90
Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix. Biomaterials (2006) 0.89
Webcasting pathology department conferences in a geographically distributed medical center. Hum Pathol (2004) 0.89
Modeling boundary conditions for balanced proliferation in metastatic latency. Clin Cancer Res (2013) 0.89
Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. Am J Clin Pathol (2006) 0.88
Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition. Breast Cancer Res Treat (2014) 0.88
Skin wound healing and scarring: fetal wounds and regenerative restitution. Birth Defects Res C Embryo Today (2012) 0.87
Motility is rate-limiting for invasion of bladder carcinoma cell lines. Int J Biochem Cell Biol (2002) 0.87
Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling. Biomaterials (2011) 0.87
Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transplant (2012) 0.87
Glutamate substitutions at a PKA consensus site are consistent with inactivation of calpain by phosphorylation. FEBS Lett (2003) 0.86
The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A (2013) 0.86
Pituitary glycoprotein hormone receptors in non-endocrine organs. Trends Endocrinol Metab (2007) 0.86
Aging-related attenuation of EGF receptor signaling is mediated in part by increased protein tyrosine phosphatase activity. Exp Cell Res (2003) 0.86
Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model. Cell Transplant (2012) 0.85